Professor Ignace Vergote is Chairman of the Leuven Cancer Institute and Head of the Department of Obstetrics and Gynaecology and Gynaecologic Oncology at the Catholic University of Leuven, Belgium. He initially trained in Obstetrics and Gynaecology at the University of Antwerp, Belgium, before specialising in Gynaecologic Oncology in the Department of Gynaecologic Oncology at the Norwegian Radium Hospital, where he later became staff member and in 1991 deputy chairman.
Professor Vergote is currently Chairman of the European Network of Gynaecological Oncological Trial groups (ENGOT), and Chairman of the Protocol committee of European Organization for Research and Treatment of Cancer - Gynecologic Cancer Group (EORTC-GCG) .
He has been Chairman of the EORTC-GCG from 1997 to 2003, and served as President of the European Society of Gynaecological Oncology (ESGO) for the period 2003-2005. For the period 2006-2008 he was the President of the International Gynecologic Cancer Society (IGCS). Currently he is the Chairman of the Flemish Society of Obstetrics and Gynaecology and Vice-President of the Society of Robotic European Gynaecological Surgery (SERGS).
He received in 2004 the Wertheim price in Austria and the COBRA price for surgical expertise in the Netherlands. In 2008 he became Honorary Member of the Finish Society of Gynaecology and Obstetrics.
Professor Vergote’s main areas of clinical and translational research focus on ovarian and uterine cancer. He has authored more than 540 original full papers in peer-reviewed journals, together with 50 book chapters, and edited several books on Gynaecological Oncology. He is also Editor of the European Journal of Cancer , and past-Associate Editor of Gynecologic Oncology and the International Journal of Gynaecological Cancer. He is also member of the Editorial Board of numerous other medical journals such as the Journal of Clinical Oncology.
Presentations by Prof. Ignace B. Vergote currently available on MultiWebcast.com
16th International meeting of the European Society of Gynaecological Oncology (ESGO)
USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.
Powered by MULTIWEBCAST Technologies. MULTIWEBCAST PLATFORM Version 4.1000. All rights reserved.